[
    {
        "title": "Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared - Benzinga",
        "description": "Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared  Benzinga",
        "published date": "Mon, 11 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vZ2VuZXJhbC9iaW90ZWNoLzIzLzA5LzM0NDM2NzgzL2xvbmdldmVyb24tbmFzZGFxLWxndm4tcmVwb3J0cy0xMDAtNS15ZWFyLXN1cnZpdmFsLWluLXRyaWFsLWZvci1yYXJlLXBlZGlhdHJpYy1kaXNlYXNlLWhsaHMtY29tcGHSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQ0MzY3ODM?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]